Harbor Capital Advisors Inc. Takes $1.94 Million Position in Oscar Health, Inc. (NYSE:OSCR)

Harbor Capital Advisors Inc. acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 91,590 shares of the company’s stock, valued at approximately $1,943,000.

A number of other institutional investors have also recently bought and sold shares of the company. Quantbot Technologies LP boosted its position in shares of Oscar Health by 435.5% during the first quarter. Quantbot Technologies LP now owns 14,495 shares of the company’s stock worth $216,000 after purchasing an additional 11,788 shares in the last quarter. Oppenheimer & Co. Inc. grew its stake in Oscar Health by 20.8% in the first quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock valued at $289,000 after acquiring an additional 3,350 shares during the period. Avalon Trust Co bought a new stake in shares of Oscar Health in the first quarter worth about $69,000. Swiss National Bank raised its position in shares of Oscar Health by 2.4% during the first quarter. Swiss National Bank now owns 263,800 shares of the company’s stock worth $3,923,000 after purchasing an additional 6,100 shares during the period. Finally, Susquehanna Fundamental Investments LLC lifted its holdings in shares of Oscar Health by 14.9% during the 1st quarter. Susquehanna Fundamental Investments LLC now owns 51,780 shares of the company’s stock valued at $770,000 after purchasing an additional 6,733 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Stock Up 2.5 %

Oscar Health stock opened at $18.09 on Tuesday. The company has a fifty day simple moving average of $18.74 and a 200 day simple moving average of $18.43. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 1-year low of $5.65 and a 1-year high of $23.79. The company has a market cap of $4.38 billion, a P/E ratio of -139.15, a price-to-earnings-growth ratio of 33.28 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. The business had revenue of $2.20 billion for the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. Oscar Health’s revenue was up 44.6% on a year-over-year basis. During the same quarter in the prior year, the company posted ($0.07) earnings per share. Research analysts anticipate that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

OSCR has been the topic of several research analyst reports. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. Piper Sandler restated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Three research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Insider Activity

In related news, CFO Richard Scott Blackley sold 68,978 shares of the business’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $1,240,914.22. Following the transaction, the chief financial officer now directly owns 884,213 shares in the company, valued at approximately $15,906,991.87. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now directly owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Richard Scott Blackley sold 68,978 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $1,240,914.22. Following the transaction, the chief financial officer now owns 884,213 shares of the company’s stock, valued at $15,906,991.87. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.